Valentin-Norbert TARUS, the biggest shareholder, having 66,5% of Farmaceutica REMEDIA (RMAH) capital, declares that only a quotation of 0,5 lei/title, double than the current share price, will consider his package shares sales” Ziarul Financiar, 15.04.2015
REMEDIA, an innovative company in the Romanian pharmaceutical industry – Interview of Mr. Valentin-Norbert TARUS, General Director of Farmaceutica REMEDIA for USA Today
06/03/2025
Read the full interview & report here.
